Explore more publications!

Vanuatu Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vanuatu Health Times.

Press releases published on November 12, 2025

Moleculin Announces Grant Funded Research Evaluating Annamycin for the Treatment of Pancreatic Cancer at UNC-Chapel Hill
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2025 Financial Results on November 17, 2025
Aprea Therapeutics Reports Third quarter 2025 Financial Results and Provides a Clinical Update
Jushi Holdings Inc. Announces Grand Opening of Beyond Hello™ Little Ferry in New Jersey
Intelligent Bio Solutions Reports Fiscal 2026 First Quarter Financial Results and Operational Highlights, Delivering Record Revenue Growth
Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO® to Australia and New Zealand
Chiesi Group Enters into an Exclusive License Agreement with Aliada Therapeutics, a Wholly Owned Subsidiary of AbbVie, to Advance Blood-Brain Barrier-Crossing Platform Technology in Lysosomal Storage Disorders
Solana Company Announces Intent to Tokenize HSDT Shares on Superstate’s Opening Bell
X9, Inc. Announces Successful Completion of First-in-Human Feasibility Study for Ultrasound-Guided, Power-Assisted Needle Insertion Device in Hemodialysis Cannulation
Standard Dental Labs Inc.: Investor Education Series — Part 2
Mainz Biomed Showcases Innovative Cancer Detection Solutions at MEDICA 2025
Evaxion announce 2026 financial calendar
Picard to Attend the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum November 20, 2025, in New York City
LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial Officer
Essity et sa marque JOBST® font équipe avec les Raptors de Toronto pour prouver que « Les armures ne sont pas toutes faites d'acier »
Collegium to Participate in Upcoming Investor Conferences
Essity Brand, JOBST®, Teams Up with Toronto Raptors to Prove that “Not All Armour is Made of Steel”
Le Centre C3i accueille Bobby Boursiquot en tant que nouveau vice-président chargé de la commercialisation
Reviva to Present Anti-Inflammatory Impacts of Brilaroxazine in Schizophrenia from the RECOVER 12-month Open Label Extension Trial at Neuroscience 2025

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions